Ibandronate sodium (generic)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ibandronate sodium (generic), covering 2020-07-31 to 2023-06-07. Get the full timeline:
Most recent: FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Macleods Pharmaceuticals Limited)